Advocacy in Action

Join Endocrine Society Advocacy to Fund NIH and the Special Diabetes Program

If you receive funding from the National Institutes of Health (NIH), your research is in jeopardy, and it is critical that Congress hear from you.

Funding for the NIH and Special Diabetes Program (SDP) expires January 30. There is a risk that Congress will not complete the funding bill for NIH and may pass another short-term funding bill, which will force NIH to continue to delay award notices for new projects and restrict funding levels. The future of SDP is also at risk because short-term extensions for SDP are disruptive for planning long-term research and programs that prevent and treat diabetes and its complications for millions of Americans.

Congress needs to hear from the endocrine community to prevent funding for NIH and SDP from expiring on January 30. We urge you to join our online campaign and take action today.

In addition to our online campaign, the Endocrine Society is leading an effort to bring together the broad research community to urge the swift passage of a final appropriations bill that protects the National Institutes of Health (NIH) and provides at least the Senate-approved funding level of $48.7 billion for NIH in fiscal year 2026 (FY26); limit the proportion of multi-year grants awarded in FY2026; and the imposition of arbitrary cap on facilities and administrative (F&A) rates. We have obtained nearly one hundred signatures from scientific organizations, professional medical associations, and patient advocacy groups on a letter to the leadership of the U.S. House of Representatives and U.S. Senate.